![The implications of identifying and managing HCC surveillance patients in General Practice Carrin Cheung Carrin Cheung](https://clinicalvalue.com/wp-content/uploads/2024/06/Carrin-Cheung.png)
27 June 2024
You are about to leave the Clinical Value website now.
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical…
READ MOREJapan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the…
READ MOREIn line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to…
READ MORE